Daray Trading

At Daray Trading, we specialize in creating streamlined access channels for patients and pharmaceutical companies across the Asia-Pacific region. With over two decades of expertise in international specialty pharmaceutical trading, we focus on rare diseases, orphan drugs, and critical therapeutic areas such as hematology, oncology, and pediatric neurology. Our team delivers comprehensive market access solutions, including clinical trial support, regulatory affairs, and strategic planning for commercial launches. Led by founder and CEO Benjamin Tsai, a registered pharmacist with extensive global industry experience, we bridge gaps between pharmaceutical innovators and patients in need. Our services extend to pre-registration named patient supply, cold chain logistics, and national health insurance reimbursement strategies.

We maintain superior relationships with local medical communities and government authorities, ensuring efficient execution of tailored market strategies. Our track record includes successful launches of over 20 orphan drugs for conditions like mucopolysaccharidosis and Duchenne muscular dystrophy. We operate with professional ethics and a forward-looking vision to maximize business goals while reducing time-to-market for life-saving therapies. Our global distribution network provides early access to hard-to-find medical products at competitive prices, even before local registration approval. Through direct partnerships with biotechnology and pharmaceutical industries, we serve as trusted representatives for contractual agreements and market expansion initiatives.